Endothelial glucocorticoid receptor promoter methylation according to dexamethasone sensitivity

Journal of Molecular Endocrinology

Volumn 55, Issue 2, 2015, Pages 133-146

  Mata Greenwood, Eugenia ^a   Jackson, P Naomi ^a   Pearce, William J ^a   Zhang, Lubo ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 UTR mRNA isoform; Endothelium; Glucocorticoids; Methylation

Indexed keywords

5 METHYLCYTOSINE; BAG1 PROTEIN; DECITABINE; DEXAMETHASONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FKBP51 PROTEIN; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR 1C; GLUCOCORTICOID RECEPTOR ALPHA; HEAT SHOCK PROTEIN 90; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN; RNA ISOFORM; UNCLASSIFIED DRUG; 5' UNTRANSLATED REGION; AZACITIDINE; DNA METHYLTRANSFERASE; GLUCOCORTICOID; ISOPROTEIN; MESSENGER RNA; NOS3 PROTEIN, HUMAN; NR3C1 PROTEIN, HUMAN; SERPINE1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; NORMAL HUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

5' UNTRANSLATED REGIONS; AZACITIDINE; CELLS, CULTURED; DEXAMETHASONE; DNA METHYLATION; DNA MODIFICATION METHYLASES; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84944312548     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0124     Document Type: Article

References (50)

1. Adcock IM, Ito K & Barnes PJ 2004 Glucocorticoids: effects on gene transcription. Proceedings of the American Thoracic Society 1 247–254. (doi:10.1513/pats.200402-001MS)
2. Alt SR, Turner JD, Klok M, Meijer OC, Lakke EAJF, DeRijk RH & Muller CP 2010 Differential expression of glucocorticoid receptor transcripts in major depressive disorder is not epigenetically programmed. Psychoneuroendocrinology 35 544–556. (doi:10.1016/j.psyneuen.2009.09.001)
3. Auphan N, DiDonato JA, Helmberg A & Karin M 1995 Immunosuppression by glucocorticoids: inhibition of NF-k B activity through induction of I k B synthesis. Science 270 232–233. (doi:10.1126/science.270.5234.286)
4. Bamberger CM, Schulte HM & Chrousos GP 1996 Molecular determinants of glucocorticoid receptor function and tissue sensitivity of glucocorticoids. Endocrine Reviews 17 245–261. (doi:10.1210/edrv-17-3-245)
5. Barnes PJ 1998 Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science 94 557–572. (doi:10.1042/cs0940557)
6. Biddie SC, Conway-Campbell BL & Lightman SL 2012 Dynamic regulation of glucocorticoid signaling in health and disease. Rheumatology 51 403–412. (doi:10.1093/rheumatology/ker215)
7. Bockmuhl Y, Murgatroyd CA, Kuczynska A, Adcock IM, Almeida OF & Spengler D 2011 Differential regulation and function of 50-Untranslated GR-Exon 1 transcripts. Molecular Endocrinology 25 1100–1110. (doi:10.1210/me.2010-0436)
8. Butler J & Kadonaga JT 2002 The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes and Development 16 2583–2592. (doi:10.1101/gad.1026202)
9. Cao-Lei L, Leija SC, Kumsta R, Wust S, Meyer J, Turner JD & Muller CP 2011 Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions. Human Genetics 129 533–543. (doi:10.1007/s00439-011-0949-1)
10. Cao-Lei L, Suwansirikul S, Jutavijittum P, Meriaux SB, Turner JD & Muller CP 2013 Glucocorticoid receptor gene expression and promoter CpG modifications throughout the human brain. Journal of Psychiatric Research 47 1597–1607. (doi:10.1016/j.jpsychires.2013.07.022)
11. Drake AJ, Mc Pherson RC, Godfrey KM, Cooper C, Lillycrop KA, Hanson MA, Meehan RR, Seckl JR & Reynolds RM 2012 An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and foetal growth. Clinical Endocrinology 77 808–815. (doi:10.1111/j.1365-2265.2012.04453.x)
12. Filiberto AC, Maccani MA, Koestler D, Wilhelm-Benartzi C, Avissar-Whiting M, Banister CE, Gagne LA & Marsit CJ 2011 Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 6 566–572. (doi:10.4161/epi.6.5.15236)
13. Gonzalez-Rodriguez PJ, Xiong F, Li Y, Zhou J & Zhang L 2014 Fetal hypoxia increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of glucocorticoid receptors. Neurobiology of Disease 65 172–179. (doi:10.1016/j.nbd.2014.01.020)
14. Goyal R, Zhang L, Blood AB, Baylink DJ, Longo LD, Oshiro B & Mata-Greenwood E 2014 Characterization of an animal model of pregnancy-induced vitamin D deficiency due to metabolic dysregulation. American Journal of Physiology. Endocrinology and Metabolism 306 256–266. (doi:10.1152/ajpendo.00528.2013)
15. Hadoke PWF, Iqbal J & Walker BR 2009 Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. British Journal of Pharmacology 156 689–712. (doi:10.1111/j.1476-5381.2008.00047.x)
16. Heitzer MD, Wolf IM, Sanchez ER, Witchel SF & DeFranco DB 2007 Glucocorticoid receptor physiology. Reviews in Endocrine & Metabolic Disorders 8 321–330. (doi:10.1007/s11154-007-9059-8)
17. Hompes T, Izzi B, Gellens E, Morreels M, Fieuws S, Pexsters A, Schops G, Dom M, Van Bree R, Freson K et al. 2013 Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. Journal of Psychiatric Research 47 880–891. (doi:10.1016/j.jpsychires.2013.03.009)
18. Huang W & Glass CK 2010 Nuclear receptors and inflammation control: molecular mechanisms and pathophysiological relevance. Atherosclerosis, Thrombosis, and Vascular Biology 30 1542–1549. (doi:10.1161/ATVBAHA.109.191189)
19. Ito K, Chung KF & Adcock IM 2006 Update on glucocorticoid action and resistance. Journal of Allergy and Clinical Immunology 117 522–543. (doi:10.1016/j.jaci.2006.01.032)
20. Juven-Gershon T & Kadonaga JT 2010 Regulation of gene expression via the core promoter and the basal transcriptional machinery. Developmental Biology 339 225–229. (doi:10.1016/j.ydbio.2009.08.009)
21. Kadmiel M & Cidlowski JA 2013 Glucocorticoid receptor signaling in health and disease. Trends in Pharmacological Sciences 34 518–530. (doi:10.1016/j.tips.2013.07.003)
22. Kassel O & Herrlich P 2007 Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Molecular and Cellular Endocrinology 275 13–29. (doi:10.1016/j.mce.2007.07.003)
23. Kimura H, Li X, Torii K, Okada T, Kamiyama K, Mikami D, Takahashi N & Yoshida H 2009 Dexamethasone enhances basal and TNF-a stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11b-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells. Nephrology, Dialysis, Transplantation 24 1759–1765.(doi:10.1093/ndt/gfn756)
24. Kino T 2007 Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids. Hormone and Metabolic Research 39 420–424. (doi:10.1055/s-2007-980193)
25. Labonte B, Zaoulay N, Yerko V, Turecki G & Brunet A 2014 Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder. Translational Psychiatry 4 e368. (doi:10.1038/tp.2014.3)
26. Lou Y, Wen C, Li M, Adams DJ, Wang M, Yang F, Morris BJ & Whitworth JA 2001 Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension. Hypertension 37 1164–1170. (doi:10.1161/01.HYP.37.4.1164)
27. Mata-Greenwood E, Liao WX, Wang W, Zheng J & Chen DB 2010 Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric oxide synthase expression in placental artery endothelial cells. Journal of Biological Chemistry 285 17348–17358. (doi:10.1074/jbc.M109.092791)
28. Mata-Greenwood E, Stewart JM, Steinhorn RH & Pearce WJ 2013 Role of BAG1 on differential sensitivity of human endothelial cells to glucocorticoids. Atherosclerosis, Thrombosis, and Vascular Biology 33 1046–1057. (doi:10.1161/ATVBAHA.113.301247)
29. Moser D, Molitor A, Kumsta R, Tatschner T, Riederer P & Meyer J 2007 The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus. World Journal of Biological Psychiatry 8 262–268. (doi:10.1080/15622970701429862)
30. Muzaffar S, Shukla N, Angelini GD & Jeremy JY 2005 Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase. British Journal of Pharmacology 145 688–697. (doi:10.1038/sj.bjp.0706235)
31. Petersen KB, Geng CD & Vedeckis WV 2004 Three mechanisms are involved in glucocorticoid receptor autoregulation in a human T-lymphoblast cell line. Biochemistry 43 10851–10858. (doi:10.1021/bi049458u)
32. Pratt WB, Morishima Y, Murphy M & Harrell M 2006 Chaperoning of glucocorticoid receptors. Handbook of Experimental Pharmacology 172 111–138. (doi:10.1007/3-540-29717-0_5)
33. Presul E, Schmidt S, Kofler R & Helmberg A 2007 Identification, tissue expression, and glucocorticoid responsiveness of alternative first exons of the human glucocorticoid receptor. Journal of Molecular Endocrinology38 79–90. (doi:10.1677/jme.1.02183)
34. Ramamoorthy S & Cidlowski JA 2013 Ligand-induced repression of the glucocorticoid receptor gene is mediated by an NCoR1 repression complex formed by long-range chromatin interactions with intragenic glucocorticoid response elements. Molecular and Cellular Biology 33 1711–1722. (doi:10.1128/MCB.01151-12)
35. Sinclair D, Fullerton JM, Webster MJ & Weickert CS 2012 Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants. PLoS ONE 7 e31720. (doi:10.1371/journal.pone.0031720)
36. Steer JH, Kroeger KM, Abraham LJ & Joyce DA 2000 Glucocorticoids suppress tumor necrosis factor-a expression by human monocytic THP-1 cells by suppressing transactivation through adjacent NF-kB and c-Jun-activating transcription factor-2 binding sites in the promoter. Journal of Biological Chemistry 275 18432–18440. (doi:10.1074/jbc.M906304199)
37. Szyf M, Weaver ICG, Champagne FA, Diorio J & Meaney MJ 2005 Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Frontiers in Neuroendocrinology 26 139–162. (doi:10.1016/j.yfrne.2005.10.002)
38. Tamura Y, Kawao N, Yano M, Okada K, Okumoto K, Chiba Y, Matsuo O & Kaji H 2015 Role of plasminogen activator inhibitor-1 in glucocorticoid- induced diabetes and osteopenia in mice. Diabetes 64 2194–2206. (doi:10.2337/db14-1192)
39. Turner JD, Schote AB, Macedo JA, Pelascini LPL & Muller CP 2006 Tissue specific glucocorticoid receptor expression, a role for alternative first exon usage? Biochemical Pharmacology 72 1529–1537. (doi:10.1016/j.bcp.2006.07.005)
40. Turner JD, Pelascini LPL, Macedo JA & Muller CP 2008 Highly individual methylation patterns of alternative glucocorticoid receptor promoters suggest individualized epigenetic regulatory mechanisms. Nucleic Acid Research 36 7207–7218. (doi:10.1093/nar/gkn897)
41. Turner JD, Alt SR, Cao L, Vernocchi S, Trifonova S, Battello N & Muller CP 2010 Transcriptional control of the glucocorticoid receptor: CpG islands, epigenetics and more. Biochemical Pharmacology 80 1860–1868. (doi:10.1016/j.bcp.2010.06.037)
42. Van der Knaap LF, Riese H, Hudziak JJ, Verbiest MMPJ, Verhulst FC, Oldehinkel AJ & van Oort FVA 2014 Glucocorticoid receptor gene (NR3C1) methylation following stressful events between birth and adolescence. The TRAILS study. Translational Psychiatry 4 e381.(doi:10.1038/tp.2014.22)
43. Walker BR 2007 Glucocorticoids and Cardiovascular Disease. European Journal of Endocrinology 157 545–559. (doi:10.1530/EJE-07-0455)
44. Wallace AD, Cao Y, Chandramouleeswaran S & Cidlowski JA 2010 Lysine 419 targets human glucocorticoid receptor for proteasomal degradation. Steroids 75 1016–1023. (doi:10.1016/j.steroids.2010.06.015)
45. Wallerath T, Godecke A, Molojavvi A, Li H, Schrader J & Forstermann U 2004 Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide 10 36–41. (doi:10.1016/j.niox.2004.01.008)
46. Wenting-van Wijk MJG, Blankenstein MA, Lafeber FPJG & Bijlsma JWJ 1999 Relation of plasma dexamethasone to clinical response. Clinical and Experimental Rheumatology 17 305–312.
47. Witzmann SR, Turner JD, Meriaux SB, Meijer OC & Muller CP 2012 Epigenetic regulation of the glucocorticoid receptor promoter 1(7) in adult rats. Epigenetics 7 1290–1301. (doi:10.4161/epi.22363)
48. Xiong F & Zhang L 2013 Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease. Frontiers in Neuroendocrinology 34 27–46. (doi:10.1016/j.yfrne.2012.11.002)
49. Yang S & Zhang L 2004 Glucocorticoids and vascular reactivity. Current Vascular Pharmacology 2 1–12. (doi:10.2174/1570161043476483)
50. Yang C, Bolotin E, Jiang T, Sladek FM & Martinez E 2007 Prevalence of the Initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 389 52–65. (doi:10.1016/j.gene.2006.09.029)